Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial.
Chen H, Nan G, Wei D, Zhai RY, Huang M, Yang WW, Xing BC, Zhu X, Xu HF, Wang XD, Zhang XY, Zhu BR, Liu P, Cao G, Gao S, Hao CY, Yang RJ, Guo JH, Zhang X, Gao K, Wang K, Wang JF, Li ZY, Zhu LZ, Ding R, Li J, Zhao L, Shao YJ, Liu HC, Xia JL, Wang L, Kong LM, Chen ZN, Bian H.
Chen H, et al. Among authors: zhu br.
J Nucl Med. 2022 Apr;63(4):556-559. doi: 10.2967/jnumed.121.262136. Epub 2021 Sep 2.
J Nucl Med. 2022.
PMID: 34475235
Free PMC article.
Clinical Trial.